Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Nov 15, 2021, after the close
10-Q filed Nov 15, 2021, 46 days after period end · 0001493152-21-028506
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | — | $7.00M | — | $1.71M |
| Net Income | -$7.04M | -$7.24M | -$17.37M | -$16.42M |
| EPS Diluted |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.07 |
| -$0.08 |
| -$0.35 |
| -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.